Skip to main content
. 2022 Apr 14;12:873020. doi: 10.3389/fonc.2022.873020

Figure 3.

Figure 3

RBM15B increases HCC resistance to sorafenib. (A) The IC50 values in different cell lines were shown. (B) Human HCC cell lines were treated with sorafenib, and the protein expression of RBM15B was assayed by qRT-PCR and Western blotting. (C) The effect of RBM15B knockdown on sorafenib resistance. (D) The effect of RBM15B overexpression on sorafenib resistance. (E) CCK-8 assay results showing the proliferation ability of HCC cells. *p < 0.05; **p < 0.01; ***p < 0.001.